Literature DB >> 18709386

Expression and function of K(v)7 channels in murine myometrium throughout oestrous cycle.

Laura A McCallum1, Iain A Greenwood, Rachel M Tribe.   

Abstract

This study represents an extensive characterisation of the expression and functional impact of KCNQ and KCNE accessory subunits in a murine uterus using a combination of quantitative reverse transcription polymerase chain reaction, Western blot analysis, patch clamp electrophysiology and isometric tension recording. The use of uterine tissue throughout the oestrous cycle provided a physiological model with which to assess hormonal regulation of these genes. Messenger ribonucleic acid for all KCNQ genes were detected throughout the oestrous cycle with the KCNQ1 message predominant. KCNE isoforms were detected at each stage of the cycle. KCNE4 was the most abundant (p < 0.0001), and KCNQ1, KCNQ5 and KCNE1 were up-regulated in metestrous (p < 0.0001). The K(v)7 channel inhibitor XE991 reduced outward K(+) currents and significantly increased spontaneous myometrial contractions (p < 0.05), whereas retigabine (K(v)7 activator) significantly relaxed uterine tissues (p < 0.001). These data are the first to characterise KCNQ and KCNE gene expression in a cell type outside of neurons and the cardiovascular system.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18709386     DOI: 10.1007/s00424-008-0567-5

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  31 in total

1.  KCNE4 is an inhibitory subunit to the KCNQ1 channel.

Authors:  Morten Grunnet; Thomas Jespersen; Hanne Borger Rasmussen; Trine Ljungstrøm; Nanna K Jorgensen; Søren-Peter Olesen; Dan A Klaerke
Journal:  J Physiol       Date:  2002-07-01       Impact factor: 5.182

2.  Expression profile and characterisation of a truncated KCNQ5 splice variant.

Authors:  Shuk Yin M Yeung; Wienke Lange; Michael Schwake; Iain A Greenwood
Journal:  Biochem Biophys Res Commun       Date:  2008-05-05       Impact factor: 3.575

3.  Inhibition of IKs in guinea pig cardiac myocytes and guinea pig IsK channels by the chromanol 293B.

Authors:  A E Busch; H Suessbrich; S Waldegger; E Sailer; R Greger; H Lang; F Lang; K J Gibson; J G Maylie
Journal:  Pflugers Arch       Date:  1996-10       Impact factor: 3.657

4.  Ancillary subunits and stimulation frequency determine the potency of chromanol 293B block of the KCNQ1 potassium channel.

Authors:  Glenna C L Bett; Michael J Morales; Derek L Beahm; Michael E Duffey; Randall L Rasmusson
Journal:  J Physiol       Date:  2006-08-03       Impact factor: 5.182

5.  KVLQT channels are inhibited by the K+ channel blocker 293B.

Authors:  M Bleich; M Briel; A E Busch; H J Lang; U Gerlach; H Gögelein; R Greger; K Kunzelmann
Journal:  Pflugers Arch       Date:  1997-08       Impact factor: 3.657

6.  Electrophysiological and functional effects of the KCNQ channel blocker XE991 on murine portal vein smooth muscle cells.

Authors:  Shuk Yin M Yeung; Iain A Greenwood
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

7.  Functional and molecular identification of ERG channels in murine portal vein myocytes.

Authors:  Susumu Ohya; Burton Horowitz; Iain A Greenwood
Journal:  Am J Physiol Cell Physiol       Date:  2002-09       Impact factor: 4.249

8.  Differential effects of estrogen and progesterone on potassium channels expressed in Xenopus oocytes.

Authors:  Chi-Ming Wong; Suk-Ying Tsang; Xiaoqiang Yao; Franky Leung Chan; Yu Huang
Journal:  Steroids       Date:  2007-11-04       Impact factor: 2.668

9.  Molecular expression and pharmacological identification of a role for K(v)7 channels in murine vascular reactivity.

Authors:  S Y M Yeung; V Pucovský; J D Moffatt; L Saldanha; M Schwake; S Ohya; I A Greenwood
Journal:  Br J Pharmacol       Date:  2007-05-21       Impact factor: 8.739

10.  Pulmonary vasoconstrictor action of KCNQ potassium channel blockers.

Authors:  Shreena Joshi; Prabhu Balan; Alison M Gurney
Journal:  Respir Res       Date:  2006-02-20
View more
  23 in total

1.  Labour pains: giving birth to new mechanisms for the regulation of myometrial contractility.

Authors:  Kenneth L Byron; Lioubov I Brueggemann
Journal:  J Physiol       Date:  2009-05-15       Impact factor: 5.182

2.  Molecular and functional characterization of Kv7 K+ channel in murine gastrointestinal smooth muscles.

Authors:  Thomas A Jepps; Iain A Greenwood; James D Moffatt; Kenton M Sanders; Susumu Ohya
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-23       Impact factor: 4.052

Review 3.  New tricks for old dogs: KCNQ expression and role in smooth muscle.

Authors:  Iain A Greenwood; Susumu Ohya
Journal:  Br J Pharmacol       Date:  2009-04       Impact factor: 8.739

4.  Participation of KCNQ (Kv7) potassium channels in myogenic control of cerebral arterial diameter.

Authors:  Xi Zoë Zhong; Maksym I Harhun; Soren P Olesen; Susumu Ohya; James D Moffatt; William C Cole; Iain A Greenwood
Journal:  J Physiol       Date:  2010-07-12       Impact factor: 5.182

5.  Vasorelaxant effects of novel Kv 7.4 channel enhancers ML213 and NS15370.

Authors:  T A Jepps; B H Bentzen; J B Stott; O V Povstyan; K Sivaloganathan; W Dalby-Brown; I A Greenwood
Journal:  Br J Pharmacol       Date:  2014-08-14       Impact factor: 8.739

Review 6.  KCNE4 and KCNE5: K(+) channel regulation and cardiac arrhythmogenesis.

Authors:  Geoffrey W Abbott
Journal:  Gene       Date:  2016-07-30       Impact factor: 3.688

7.  KCNQ5 activation is a unifying molecular mechanism shared by genetically and culturally diverse botanical hypotensive folk medicines.

Authors:  Rían W Manville; Jennifer van der Horst; Kaitlyn E Redford; Benjamin B Katz; Thomas A Jepps; Geoffrey W Abbott
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-30       Impact factor: 11.205

Review 8.  One man's side effect is another man's therapeutic opportunity: targeting Kv7 channels in smooth muscle disorders.

Authors:  T A Jepps; S P Olesen; I A Greenwood
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

9.  Treatment with the Kv7 potassium channel activator flupirtine is beneficial in two independent mouse models of pulmonary hypertension.

Authors:  I Morecroft; A Murray; M Nilsen; A M Gurney; M R MacLean
Journal:  Br J Pharmacol       Date:  2009-06-05       Impact factor: 8.739

10.  Kv7.5 Potassium Channel Subunits Are the Primary Targets for PKA-Dependent Enhancement of Vascular Smooth Muscle Kv7 Currents.

Authors:  Bharath K Mani; Christina Robakowski; Lyubov I Brueggemann; Leanne L Cribbs; Abhishek Tripathi; Matthias Majetschak; Kenneth L Byron
Journal:  Mol Pharmacol       Date:  2015-12-23       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.